نتایج جستجو برای: hsct

تعداد نتایج: 3502  

Journal: :Biopsychosocial Medicine 2008
Wataru Fukuo Kazuhiro Yoshiuchi Yoshiyuki Takimoto Noriyuki Sakamoto Hiroe Kikuchi Maki Hachizuka Shuji Inada Yasuhito Nannya Keiki Kumano Tsuyoshi Takahashi Mineo Kurokawa Akira Akabayashi

BACKGROUND Although hematopoietic stem cell transplantation (HSCT) can potentially cure some hematological malignancies, patients who undergo HSCT experience psychological distress. However, there have been few studies on the short-term influence of HSCT on psychological distress. METHODS The subjects were 71 patients with hematological malignancies who underwent HSCT: 33 with acute leukemia,...

2012
Yun-Hee Lee Ji-Yoon Kim Byung-Ock Choi Mi-Ryeong Ryu Su-Mi Chung

PURPOSE To retrospectively evaluate the outcome and toxicity of total lymphoid irradiation (TLI) based conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in severe aplastic anemia (SAA) patients who experienced an engraftment failure from prior HSCT or were heavily transfused. MATERIALS AND METHODS Between 1995 and 2006, 20 SAA patients received TLI for conditi...

2015
Atsushi Manabe Hirohide Kawasaki Hiroyuki Shimada Itaru Kato Yuichi Kodama Atsushi Sato Kimikazu Matsumoto Keisuke Kato Hiromasa Yabe Kazuko Kudo Motohiro Kato Tomohiro Saito Akiko M Saito Masahito Tsurusawa Keizo Horibe

Incorporation of imatinib into chemotherapeutic regimens has improved the prognosis of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL). We investigated a role of imatinib immediately before hematopoietic stem cell transplantation (HSCT). Children with Ph(+) ALL were enrolled on JPLSG Ph(+) ALL 04 Study within 1 week of initiation of treatment for ALL. Tre...

Journal: :Blood 2017
Theo de Witte David Bowen Marie Robin Luca Malcovati Dietger Niederwieser Ibrahim Yakoub-Agha Ghulam J Mufti Pierre Fenaux Guillermo Sanz Rodrigo Martino Emilio Paolo Alessandrino Francesco Onida Argiris Symeonidis Jakob Passweg Guido Kobbe Arnold Ganser Uwe Platzbecker Jürgen Finke Michel van Gelder Arjan A van de Loosdrecht Per Ljungman Reinhard Stauder Liisa Volin H Joachim Deeg Corey Cutler Wael Saber Richard Champlin Sergio Giralt Claudio Anasetti Nicolaus Kröger

An international expert panel, active within the European Society for Blood and Marrow Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group, and the International Myelodysplastic Syndromes Foundation developed recommendations for allogeneic hematopoietic stem cell transplantation (HSCT) in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CM...

2017
Trude Reinfjell Marta Tremolada Lonnie K. Zeltzer

Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and failure of conventional treatments for cancer in childhood or as a first line treatment for some high-risk cancers. Since hematopoietic stem cells can be found in the marrow (previously called a bone marrow transplantation) or periphery, we refer to HSCT as inclusive of HSCT regardless of the origin...

2016
Haowen Xiao Li-Mengmeng Wang Yi Luo Xiaoyu Lai Caihua Li Jimin Shi Yamin Tan Shan Fu Yebo Wang Ni Zhu Jingsong He Weiyan Zheng Xiaohong Yu Zhen Cai He Huang

Although steady improvements to chemotherapeutic treatments has helped cure 80% of childhood acute lymphoblastic leukemia (ALL) cases, chemotherapy has proven to be less effective in treating the majority of adult patients, leaving allogeneic hematopoietic stem cell transplantation (allo-HSCT) as the primary adult treatment option. Nevertheless relapse are the leading cause of death following a...

2013
Dae Hyun Kwon Seungwon Jung Eun-Jung Lee Jae Young Lee Sena Moon Jae Wook Lee Nack Gyun Chung Bin Cho Hack Ki Kim

BACKGROUND AND OBJECTIVES Survivors of pediatric hematopoietic stem cell transplantation (HSCT) are at risk for developing hypertension. The objectives of this study are to evaluate the prevalence and risk factors of early onset hypertension during the engraftment period after HSCT. SUBJECTS AND METHODS This is a retrospective study of 157 consecutive patients (mean age at HSCT: 9.1±5.1 years...

2011
Jae Wook Lee Nack Gyun Chung

Childhood chronic myelogenous leukemia (CML) is a rare hematologic disease, with limited literature on the methods of treatment. Previously, allogeneic hematopoietic stem cell transplantation (HSCT) was considered the only curative treatment for this disease. Treatment with imatinib, a selective inhibitor of the BCR-ABL tyrosine kinase (TKI), has resulted in prolonged molecular response with li...

Journal: :Journal of clinical and experimental hematopathology : JCEH 2017
Noriaki Kawano Takuro Kuriyama Shuro Yoshida Sayaka Kawano Yoshihisa Yamano Kousuke Marutsuka Seiichirou Minato Kiyoshi Yamashita Hidenobu Ochiai Kazuya Shimoda Fumihiko Ishikawa Ikuo Kikuchi

Although a humanized CCR4 antibody (mogamulizumab) was reported to be effective for refractory adult T-cell leukemia-lymphoma (ATL), several reports regarding the use of mogamulizumab before allo-hematopoietic stem cell transplantation (HSCT) strongly indicated a high incidence of severe acute graft-versus-host-disease (GVHD) and treatment-related mortality (TRM). We retrospectively analyzed ni...

Journal: :Journal of Dentistry Open Access 2021

Aplastic anaemia is a severe haematological disorder characterized by an inadequate number of hematopoietic stem cells, resulting in pancytopenia, formed hypocellular bone marrow. Disorders this nature are widely treated with haematopoietic cell transplantation (HSCT). A potential chronic complication following (HSCT) the growth secondary malignancies. Notably, patients suffering from graft ver...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید